Radioimmunoassay of LTB4 in plasma from different species: a cautionary note

• Published in: Prostaglandins, leukotrienes and essential fatty acids Vol. 36; no. 1; pp. 57 - 61
• Main Authors: CAREY, F, FORDER, R. A, GIBSON, K. H, HAWORTH, D
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier 01.04.1989
• Subjects: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Aminoacids, peptides. Hormones. Neuropeptides; Analytical, structural and metabolic biochemistry; Animals; Biological and medical sciences; Calcimycin - pharmacology; Chromatography, High Pressure Liquid - methods; Cross Reactions; Cyclooxygenase Inhibitors; Fundamental and applied biological sciences. Psychology; Humans; Hydroxyeicosatetraenoic Acids - blood; Hydroxyeicosatetraenoic Acids - isolation & purification; Leukotriene B4 - blood; Leukotriene B4 - isolation & purification; Lipoxygenase Inhibitors; Mice; Proteins; Radioimmunoassay; Rats; Species Specificity; Thromboxane B2 - blood; Vertebrata; Mammalia; Leukotriene B4; Arachidonic acid derivatives; Radioimmunoassay; HPLC chromatography; Rabbit; Lagomorpha; HETE; Blood plasma
• ISSN: 0952-3278; 1532-2823
• DOI: 10.1016/0952-3278(89)90163-4

In clinical and pre-clinical research the pharmacodynamics of selective 5-lipoxygenase and dual 5-lipoxygenase/cyclo-oxygenase inhibitors may be studied by direct RIA of plasma LTB4. Although immunoreactive LTB4 in plasma from A23187 stimulated human blood has the characteristics of authentic LTB4 our results show, particularly in mice and rats, that exposure to A23187 produces large quantities of 12-HETE. Since in different species the levels of 12-HETE increase with platelet concentration we suggest that the 12(S)-HETE is produced by platelet lipoxygenase. However, we do not rule out the possibility that a proportion of 12-HETE may exist as the (R)-stereoisomer. The latter has greater potential for interference in the direct RIA of LTB4. Biosynthesis of 12-HETE may be measured either by RPHPLC/U.V. abs. (8) or by RIA (9) and LTB4 by a more specific antibody described in this report. We conclude that the combined ex vivo RIA of plasma TXB2, LTB4 and 12-HETE has utility in determining the selectivity of inhibitors of arachidonate metabolism and in distinguishing between selective 5-lipoxygenase inhibitors which interact directly with the enzyme and anti-oxidant or free radical scavenging types which may be less specific.